Pharmafile Logo
Pharmafocus logo
Advanced Search
margaret_hamburg

Former FDA commissioner named as Institute of Medicine foreign secretary

April 9, 2015
Manufacturing and Production, Medical Communications, Research and Development Dr Margaret Hamburg, FDA, IOM, Institute of Medicine, Margaret Hamburg

Former commissioner of the US Food and Drug Administration Margaret Hamburg has been appointed as the next foreign secretary of …

Appointment
beverly_hope_cello

Cello Health Consulting gains senior marketer

April 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, beverly hope, consulting, health

Healthcare strategic marketing consultancy Cello Health Consulting has appointed pharma marketer Beverly Hope as a senior consultant for its brand and portfolio …

Appointment
Gilead image

Gilead’s next-generation HIV drug to be FDA assessed

April 8, 2015
Research and Development, Sales and Marketing F/TAF, FDA, Gilead, HIV, Tenofovir Alafenamide, emtricitabine

Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …

News
Amgen image

Amgen’s colorectal cancer drug EU approved

April 8, 2015
Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa

The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …

News
Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

News
Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

News
konstantinos_kosmatopoulos

Vaxon Biotech appoints founder as chief executive

April 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Konstantinos Kosmatopoulos, vaxon biotech

Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …

Appointment
Dubai skyline

Takeda expands in the United Arab Emirates

April 7, 2015
Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east

Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …

News

Antibiotic resistance outbreak ‘could kill 80,000’, report warns

April 7, 2015
Research and Development, Sales and Marketing AMR, Nabriva Therapeutics, antibiotic resistance, bacteria, blood infections, infections

An antibiotic-resistant blood infection outbreak could lead to 80,000 deaths, according to a government report on threats to the UK. …

News

Hundreds of jobs threatened after big pharma deals close

April 7, 2015
Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix

Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …

News
Market access means new drugs are available to prescribe to patients

Refining UK market access

April 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access

“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …

Feature
BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

News
Shire image

Shire plots new ADHD drug approval

April 7, 2015
Sales and Marketing ADHD, FDA, SHP465, Shire, Vyvanse, clinical trials, paediatrics

Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …

News
Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

News
Mosquito image

Merck Serono signs antimalarial development deal

April 2, 2015
Research and Development, Sales and Marketing DDD107498, Medicines for Malaria Venture, Merck Serono, antimalarial, malaria

Merck Serono and Medicines for Malaria Venture (MMV) have signed an agreement which will see them advance the development of …

News
Rilutek (riluzole) image

Multiple sclerosis studies underway using existing drugs

April 2, 2015
Research and Development, Sales and Marketing MS, Midamor, Prozac, Rilutek, Sanofi, amiloride, covis, fluoxetine, multiple sclerosis, riluzole

Three existing drugs that fight heart disease, depression and motor neurone disease could be used to treat multiple sclerosis (MS) …

News
Thomas Webb image

Working Life: GlaxoSmithKline’s Thomas Webb

April 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Hong Kong, Working Life, macau, oncology, thomas webb

Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …

Feature
Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

News
jonathandancer_1

PM Society appoints two new members

April 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing colin williams, jonathan dancer, pm society

Not-for-profit healthcare marketing organisation PM Society has made two new appointments to its executive committee.  Jonathan Dancer (pictured) the managing …

Appointment
Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026